Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 40Rectal Neoplasms 21Colorectal Neoplasms 20Colonic Neoplasms 19Glioblastoma 13Pancreatic Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Stomach Neoplasms 11Gliosarcoma 11Central Nervous System Neoplasms 11Esophageal Neoplasms 9Prostatic Neoplasms 8Lung Neoplasms 8Head and Neck Neoplasms 8Uterine Cervical Neoplasms 7Carcinoma, Intraductal, Noninfiltrating 7Adenocarcinoma Of Esophagus 7Squamous Cell Carcinoma of Head and Neck 6Sarcoma 6Ovarian Neoplasms 6Neoplasm Metastasis 6Carcinoma, Ovarian Epithelial 6Breast Neoplasms, Male 6Melanoma 5Esophageal Squamous Cell Carcinoma 5Breast Carcinoma In Situ 5Salivary Gland Neoplasms 4Nasopharyngeal Carcinoma 4Lymphoma 4Fallopian Tube Neoplasms 4

Interventions

Cyclophosphamide 165fludarabine phosphate 110Peripheral Blood Stem Cell Transplantation 94Mycophenolic Acid 88Whole-Body Irradiation 81Etoposide 81Tacrolimus 73Busulfan 68Melphalan 67Filgrastim 66fludarabine 62Radiotherapy 56Doxorubicin 54Cyclosporine 54Rituximab 50Brentuximab Vedotin 48Antilymphocyte Serum 47Granulocyte Colony-Stimulating Factor 42Vinblastine 41Methotrexate 38Dacarbazine 37Cytarabine 35Gemcitabine 34Nivolumab 30Bleomycin 29Carmustine 28Vincristine 25Prednisone 25Sirolimus 24Bendamustine Hydrochloride 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hodgkin Disease × Chemotherapy, Adjuvant × Clear all
NCT00478062 2018-02-28

Vaccine Therapy in Treating Patients Who Have Received First-Line Therapy for Hodgkin's Lymphoma

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 1/2 Terminated
1 enrolled 3 charts
Lymphoid

Hodgkin Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡